Aphria Inc (APHA)
$6.16 0.11 (1.82%)
19:21 EDT APHA Stock Quote Delayed 15 Minutes
Previous Close $6.16
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 2.75M
Day's Range 5.93 - 6.22
52-Week Range 3.75 - 13.45
Dividend & Yield N/A (N/A)
APHA Stock Predictions, Articles, and Aphria Inc News
- From InvestorPlace
- From the Web
Aphria stock has managed what many marijuana stocks haven't -- regular quarterly profits. Plus, AMD stock may be headed to a better buy point.
Aphria stock has incurred its fair share of controversies, which has led to severe volatility. But with the ugliness priced in, a deeper look into APHA reveals a surprisingly solid name.
Aphria stock had impressive earnings in August and has been quietly outperforming most of its peers over the past six months.
These stocks to buy base at least some of their revenue on CBD and are poised to buck the downtrend that has hit the larger cannabis stocks.
Throughout this year, marijuana-related investments like Aurora Cannabis stock took a massive beating. Still, markets work in cycles and with ACB not dropping to new lows, it suggests a possible turnaround is coming with the right catalyst.
While oil stocks garnered the bulk of attention from many investors, readers were also interested in marijuana stocks and Nio.
Stepping into Aphria stock now is a little bit like catching a falling knife. Just wait for it to hit the floor.
Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.
By Thomas Niel
Aphria stock sells at a deep discount to peers. But the company's recent scandals could be a red flag. Keep APHA stock on your radar.
APHA stock is in the early stages of going from secular loser to secular winner, joining the ranks with CGC as a top pot stock.
Aurora Cannabis stock is drifting lower for a reason, even of most investors are struggling to articulate it as earnings news nears.
The rally in Aphria stock on August 2 faded. But investors are ignoring the long-term potential growth ahead.
These 10 stocks, including APHA, posted monster earnings. But are they still the best stocks to buy, or has the market now caught up?
Not long ago, the prospects for Aphria stock did not look great. But the new CEO has done a standout job , improving the outlook of APHA stock. And the latest earnings report is evidence of this.
APHA reported surprisingly strong earnings.. Since then, Aphria stock is up almost 20%. But the company still has some work to do.
Wall Street’s impatience to see progress on the bottom line have hurt marijuana stocks. However, positive catalysts, such as a support political environment and individual companies’ push toward mainstreaming cannabis bolster the case for the embattled weed market.
Aphria stock is a controversial name levered toward an industry that doesn’t lack in controversy. That so many people are willing to stick their necks out for APHA implies that the bad news may not be so bad after all.
CGC stock is at a crucial technical juncture as Canopy Growth approaches the release of last quarter's numbers. Other pot stocks are apt to follow its lead.
Marijuana stock investor have been dealing with negative investor sentiment for several months now. However, a new Cronos CBD deal and a huge positive reaction to Aphria earnings may have turned the tide.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!